14 October 2013 - Deborah Wilkes
Archived
Sanofi is set to launch the OTC version of its Nasacort AQ (triamcinolone acetonide) nasal spray in the US in early 2014.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.